These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6836774)

  • 1. [Prevention of coronary disease: role of high density lipoproteins (HDL)].
    Pouliot M
    Union Med Can; 1983 Jan; 112(1):28-30. PubMed ID: 6836774
    [No Abstract]   [Full Text] [Related]  

  • 2. [High-density lipoproteins in children with coronary diseases].
    Oberhänsli I; Pometta D; Micheli H; Raymond L
    Helv Paediatr Acta; 1981; 36(2):135-47. PubMed ID: 7251385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The LDL-HDL ratio in patients with coronary arteriosclerosis (author's transl)].
    Zimmer F; Riebeling V; Benke B; Schuster J; Roskamm H
    Z Kardiol; 1980 Mar; 69(3):149-53. PubMed ID: 7456590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
    Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ
    Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High and low density lipoprotein abnormalities in coronary patients with LDL-C at target and uncontrolled HDL-C and triglycerides].
    Posadas-Romero C; Posadas-Sánchez R; Juárez-Rojas JG; Medina-Urrutia A; Jorge-Galarza E; Cardoso-Saldaña G; Caracas-Portilla N; Mendoza-Peŕez E
    Arch Cardiol Mex; 2008; 78(1):30-9. PubMed ID: 18581711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [LDL-cholesterol and HDL-cholesterol--risk factor and safety factor? Conclusions for therapy].
    Wolfram G; Schlierf G
    Internist (Berl); 1979 Dec; 20(12):613-8. PubMed ID: 232882
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma lipoprotein cholesterol and coronary heart disease.
    Misra KP; Suresh S; Balachandran G; Reddy KN; Rao PM; Radhakrishnan T; Shanmugasundaram KR
    J Assoc Physicians India; 1980 Nov; 28(11):399-404. PubMed ID: 7216970
    [No Abstract]   [Full Text] [Related]  

  • 8. Lipid measurements for coronary risk assessment: a review.
    Berg LH
    Am J Med Technol; 1981 Jul; 47(7):539-43. PubMed ID: 7025628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Another coronary risk factor--HDL cholesterol.
    Sannella JJ
    J Tenn Med Assoc; 1977 May; 70(5):334. PubMed ID: 194113
    [No Abstract]   [Full Text] [Related]  

  • 10. The peculiarities of lipid and protein components of the high- and low-density lipoproteins in patients suffering from coronary atherosclerosis with different number of affected coronary arteries.
    Gasilin VS; Kurdanov KhA; Perova NV; Torkhovskaya TI; Polessky VA; Matveeva LS
    Cor Vasa; 1981; 23(4):248-56. PubMed ID: 7297073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipoproteins and coronary cardiopathy].
    Angelino PF; Abrate M; Pizzuti A; Bernardi FR; Bulgarelli GC; Aillon C; Passarino G; Carta Q; Della Beffa V
    Minerva Cardioangiol; 1981 Apr; 29(4):163-7. PubMed ID: 7242947
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum cholesterol binding reserve (SCBR) in coronary artery disease.
    Chandra R; Sikka KK; Kumar S; Srivastava DK
    Indian Heart J; 1980; 32(6):355-60. PubMed ID: 7228084
    [No Abstract]   [Full Text] [Related]  

  • 13. LDL and HDL subclasses and their relationship with Framingham risk score in middle-aged Serbian population.
    Vekic J; Topic A; Zeljkovic A; Jelic-Ivanovic Z; Spasojevic-Kalimanovska V
    Clin Biochem; 2007 Mar; 40(5-6):310-6. PubMed ID: 17291473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The lipoproteic state in patients with coronary heart disease (author's transl)].
    Catalano M; Carzaniga G; Garimoldi M; Sala R; Castelfranco M; Libretti A
    G Ital Cardiol; 1981; 11(12):1944-7. PubMed ID: 7346295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microchip-based small, dense low-density lipoproteins assay for coronary heart disease risk assessment.
    Wang H; Wang HM; Jin QH; Cong H; Zhuang GS; Zhao JL; Sun CL; Song HW; Wang W
    Electrophoresis; 2008 May; 29(9):1932-41. PubMed ID: 18384042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of hyperlipidemia in coronary artery disease.
    Kossmann CE
    J Tenn Med Assoc; 1982 Aug; 75(8):543-7. PubMed ID: 7132342
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical significance of HDL-cholesterol].
    Reuter W; Herrmann W
    Z Gesamte Inn Med; 1981 Jul; 36(14):473-9. PubMed ID: 6944971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health study.
    März W; Scharnagl H; Winkler K; Tiran A; Nauck M; Boehm BO; Winkelmann BR
    Circulation; 2004 Nov; 110(19):3068-74. PubMed ID: 15505088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoproteins, cardiovascular disease, and death. The Framingham study.
    Gordon T; Kannel WB; Castelli WP; Dawber TR
    Arch Intern Med; 1981 Aug; 141(9):1128-31. PubMed ID: 7259370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Levels of lipoprotein fractions in ischaemic cerebral disease (author's transl)].
    Deisenhammer E; Sommer R; Teufl W
    Wien Klin Wochenschr; 1982 Jan; 94(2):42-3. PubMed ID: 7080496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.